MIGS, licensing agreements rank among most-read glaucoma coverage
Click Here to Manage Email Alerts
December glaucoma news includes updates on standalone MIGS surgery as well as a video from the American Academy of Ophthalmology meeting.
Read the top-performing pieces of glaucoma coverage from December below.
First patient enrolled in stand-alone Hydrus microstent trial
The first patient has been enrolled in a trial investigating the stand-alone use of the Hydrus microstent in mild to moderate open-angle glaucoma, according to a press release from Ivantis. Read more.
Woman’s IOP elevated despite patent laser peripheral iridotomy
A 58-year-old white woman with primary angle closure suspect was referred to the New England Eye Center glaucoma service for elevated IOP after bilateral laser peripheral iridotomy. Read more.
VIDEO: Surgeon explains benefits of ECP to treat glaucoma
NEW ORLEANS — In this Healio Video Perspective from the AAO meeting, Philip Bloom, MD, discusses the role of endoscopic cyclophotocoagulation in the surgical management of glaucoma. Watch more.
Aerie, Santen reach licensing agreement for glaucoma drugs
Aerie and Santen have entered an agreement for Rhopressa and Rocklatan in Europe, China, India, Commonwealth of Independent State countries, parts of Latin America and Oceanic countries, according to a company press release. Read more.